Skip to main content
2024 CRT Conference Main banner
Back

Late-Breaking

Late-Breaking Clinical Trials - Drug Coated Balloon & Pharma [Non-CME]

Late-Breaking Clinical Trials | Drug Coated Balloon & Pharma [Non-CME]

Saturday, March 9, 2024
2:00 PM – 3:15 PM ET

    Moderator(s)

  • Gregg Stone, MD, FACC, MSCAI

    Physician
    Mount Sinai
    New York, New York, United States

  • Antonio Colombo, MD

    Professor of Cardiology
    Humanitas IRCCS
    Milan, Lombardia, Italy

    • Panel Discussant(s)

  • J. Dawn Abbott, MD

    Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University
    Brown University
    Providence, Rhode Island, United States

  • David Cohen, MD, FSCAI

    Director of Clinical and Outcomes Research
    Cardiovascular Research Foundation
    New York, New York, United States

  • Bernardo Cortese, MD, FESC, FSCAI

    consultant Cardiologist
    Fondazione Ricerca e Innovazione Cardiovascolare
    Milano, Lombardia, Italy

  • Paul Gurbel, MD, FSCAI

    Director
    Sinai Center for Thrombosis Research and Drug Development
    Baltimore, Maryland, United States

  • Azeem Latib, MD

    Director, Interventional Cardiology & Structural Heart Interventions
    Montefiore Medical Center
    Scarsdale, New York, United States

Disclosure(s):
Antonio Colombo, MD: No relationships to disclose
David J. Cohen, MD, FSCAI: No relationships to disclose
C. Michael Gibson, MD: Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); BOEHRINGER INGELHEIM IT.SpA.: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); Esperion: Consultant (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Consultant (Ongoing), Shareholder (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); New Amsterdam Pharma: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Samsung: Consultant (Ongoing); SCAD Alliance: Consultant (Ongoing); SCAI: Consultant (Ongoing); SFJ: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)
Paul A. Gurbel, MD, FSCAI: No relationships to disclose
Azeem Latib, MD: No relationships to disclose

Presentations:

  • 2:00 PM – 2:10 PM ET
    Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis – Primary Outcomes from the Full Population of the AGENT IDE Trial

    Speaker: Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center

  • 2:10 PM – 2:20 PM ET
    Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty for In-Stent Restenosis: A Nationwide Segment-Level Analysis from SCAAR of 7987 Patients

    Speaker: David Erlinge, MD, PhD – Lund University

  • 2:20 PM – 2:35 PM ET
    Panel Discussion
  • 2:35 PM – 2:45 PM ET
    Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: A Comprehensive, Individual Patient Data Meta-Analysis of Randomized Clinical Trials: The ANDROMEDA Study

    Speaker: Bernardo Cortese, MD, FESC, FSCAI – Fondazione Ricerca e Innovazione Cardiovascolare

  • 2:45 PM – 2:55 PM ET
    Panel Discussion
  • 2:55 PM – 3:05 PM ET
    Ticagrelor Monotherapy in Patients with Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis of Randomized TICO and T-PASS Trials

    Speaker: Myeong-Ki Hong, MD – Yonsei University College of Medicine, Severance Hospital

  • 3:05 PM – 3:15 PM ET
    Panel Discussion
  • 3:15 PM ET
    Adjourn